Originally published byEU-Startups
Vienna-based Epitome Therapeutics, a BioTech company advancing precision epigenome editing for programmable gene expression, today announced a total funding of €4 million to advance development programmes and grow the company’s team. The pre-seed round, comprising an oversubscribed €2 million pre-seed round and €2 million in non-dilutive grant funding, was co-led by XISTA Science Ventures and […]
The post Austrian BioTech startup Epitome Therapeutics announces €4 million in funding to advance programmes and grow team appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Finland’s CurifyLabs raises €12 million to expand 3D printing-based medicine compounding
22h ago
NASA says it will isolate volunteers from the outside world for a year
3d ago
NetNut cracked as Google and FBI target 2 million-device botnet
3d ago
Google DeepMind and A24 announce first-of-its-kind research partnership
3d ago
London’s geoSurge raises €10 million to help brands understand AI-generated outputs
3d ago